Appreciation of humorous scenes is associated with specific electrical activity in the brain
Does humor appreciation have a brain signature? In a new study published in Neuropsychologia, Vadim Axelrod at Bar-Ilan University in Tel Aviv, in collaboration with Lionel Naccache (Sorbonne University, AP-HP) at Paris Brain Institute, decrypts the...
05.19.2023
Research, science & health
Multiple sclerosis: a new tool to reduce clinical failure
No treatment currently exists that can stop the silent progression of multiple sclerosis, and many promising drugs have proved ineffective in clinical trials. To reduce this failure rate and better predict the potential of candidate molecules...
03.03.2023
Research, science & health
In bilingual readers, the visual cortex processes Latin and Chinese characters differently
Nearly half of humanity speaks more than one language, and many adults can read and master several writing systems. How does the visual cortex adapt to the recognition of words written with different characters? To answer this question, Laurent Cohen...
04.14.2023
Research, science & health
Status epilepticus: new inflammatory markers to improve patient care
Unlike classic epileptic seizures that last only a few seconds or minutes, " status epilepticus" refers to a state of neuronal hyperactivity in the cerebral cortex that persists for several hours or days. When this condition occurs without a readily...
03.31.2023
Research, science & health
Cellular senescence plays a significant role in cerebral tumors
Glioblastomas are the most common malignant tumors of the adult brain. They resist conventional treatment, including surgery, followed by radiation therapy and chemotherapy. Despite thisarmamentarium, glioblastomas inexorably recur. In a new study...
02.24.2023
Research, science & health
Enjoying now or saving for later: are we predisposed to choose?
Léonie KOBAN and Hilke PLASMANN, researchers in the team "CIA: cognitive control - interoception - attention", have identified a novel brain marker using functional imaging that predicts our preference for immediate rewards over larger later rewards...
02.23.2023
Research, science & health
Oxygen therapy subsides abnormal movements in a rare childhood disease
Researchers led by Emmanuel Flamand-Roze, at Paris Brain Institute, have shown that a simple administration of oxygen can alleviate abnormal movement attacks in an orphan disease – alternating hemiplegia of childhood (AHC). These encouraging...
02.21.2023
Research, science & health
Sensory cells taste the cerebrospinal fluid to fight brain infections
Sensory neurons pick up information from our senses and relay it to the rest of the nervous system. But this is not their only mission. In a new study published in the journal Current Biology, Claire Wyart at Paris Brain Institute, and Christina...
02.20.2023
Research, science & health
Two researchers from the Paris Brain Institute rewarded by the 2022 ERC
The European Research Council (ERC) has just published the list of the winners of the grants it is about to distribute. This year, two researchers from at the Paris Brain Institute have been distinguished.
02.07.2023
Research, science & health
A subtitled world: uncovering tickertape synesthesia
The acquisition of reading and writing are complex mechanisms whose subtleties we do not yet understand. Fabien Hauw and Laurent Cohen (Inserm, CNRS, Sorbonne University, AP-HP), neurologists at Paris Brain Institute, hope to uncover how we connect...
02.03.2023
Research, science & health
Towards better management of disinhibition in frontotemporal dementia
Disinhibition is one of the main symptoms of the behavioural variant frontotemporal dementia (bvFTD), a type of dementia associated with degeneration of the frontal and temporal lobes of the brain. Patients with bvFTD exhibit behaviours that are...
01.30.2023
Research, science & health
New drug candidate slows the progression of adrenoleukodystrophy
The work of Professor Fanny Mochel (AP-HP, Sorbonne University) at Paris Brain Institute, in collaboration with clinical research teams in eight countries and Spanish biotech Minoryx Therapeutics, has demonstrated the protective effects of...
01.20.2023
Research, science & health